haloperidol decanoate has been researched along with Psychoses in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (38.10) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bernal, JA; Bez, Y; Coffey, BJ; Zaydlin, M | 1 |
| Bialko, CS; Cassidy, KA; Fuentes-Casiano, E; Hahn, DY; Levin, J; Ramirez, LF; Sajatovic, M; Tatsuoka, C; Williams, TD | 1 |
| Gedzior, JS; Matthew, BJ | 1 |
| Byerly, MJ; Hamer, RM; Leslie, DL; Li, Y; Lin, H; McEvoy, JP; Rosenheck, RA; Sint, KJ; Stroup, TS; Swartz, MS | 1 |
| Citrome, L; Jaffe, A; Levine, J | 1 |
| Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA | 1 |
| Becker, T; Kopf, A; Köster, J; Krömker, H; Schulz, A | 1 |
| Glick, ID; Marder, SR | 1 |
| Adetunji, B; Basil, B; Mathews, M; Osinowo, T; Williams, A | 1 |
| Alexandre, JY; Clerc, G; Darondel, A; Delaunay, J; Delteil, P; Leger, JM; Lemperiere, T; Malauzat, D; Raynaud, J; Ropert, R | 1 |
| Fernando, J; Jones, GG; Krishna Raju, R; Stanley, RO | 1 |
| Freudenreich, O; McEvoy, JP | 1 |
| Anderson, C; Ereshefsky, L; Saklad, SR; Seidel, D; Toney, G | 1 |
| Dysken, MW; Holden, L; Johnson, SB; Kim, SW; Skare, S; Thomsyck, L; Vatassery, G | 1 |
| Christodoulou, GN; Kontaxakis, VP; Vaidakis, NM; Valergaki, HC | 1 |
| Brizuela, A; Caruso, S; Cuervo, L; Marchant, N | 1 |
| Bollen, J; De Cuyper, H; van Praag, HM; Verstraeten, D | 1 |
| Alvarez, JV; Li Gambi, M | 1 |
| James, WA; Pary, R; Tobias, CR; Turns, DM | 1 |
| Ellerman, LA | 1 |
| Beresford, R; Ward, A | 1 |
2 review(s) available for haloperidol decanoate and Psychoses
| Article | Year |
|---|---|
[Life threatening neuroleptic malignant syndrome due to olanzapine].
Topics: Antipsychotic Agents; Benzodiazepines; Critical Care; Electroconvulsive Therapy; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Recurrence | 2003 |
Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis.
Topics: Haloperidol; Humans; Psychotic Disorders | 1987 |
5 trial(s) available for haloperidol decanoate and Psychoses
| Article | Year |
|---|---|
Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Delayed-Action Preparations; Female; Haloperidol; Hospitalization; Humans; Ill-Housed Persons; Injections, Intramuscular; Male; Medication Adherence; Prospective Studies; Psychiatric Status Rating Scales; Psychological Techniques; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; United States | 2013 |
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Injections; Male; Middle Aged; Outcome Assessment, Health Care; Paliperidone Palmitate; Patient Acceptance of Health Care; Psychotic Disorders; Quality-Adjusted Life Years; Schizophrenia; United States; Young Adult | 2016 |
Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Female; Haloperidol; Humans; Incidence; Injections, Intramuscular; Long-Term Care; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Treatment Outcome | 2005 |
[Evaluation of the efficacy of haloperidol decanoate].
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychotic Disorders | 1986 |
[Open clinical trial with haloperidol decanoate in patients with psychotic disorders].
Topics: Clinical Trials as Topic; Female; Haloperidol; Humans; Male; Psychotic Disorders | 1987 |
14 other study(ies) available for haloperidol decanoate and Psychoses
| Article | Year |
|---|---|
Improved Treatment Outcome with Haloperidol Decanoate and Amantadine in an Adolescent with Schizoaffective Disorder.
Topics: Adolescent; Amantadine; Antipsychotic Agents; Haloperidol; Humans; Psychotic Disorders; Treatment Outcome | 2023 |
Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate.
Topics: Adult; Amphetamine-Related Disorders; Diphenhydramine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Injections, Intramuscular; Male; Methamphetamine; Neural Pathways; Nucleus Accumbens; Parkinson Disease, Secondary; Patient Admission; Patient Readmission; Psychotic Disorders; Receptors, Dopamine D2; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Substantia Nigra; Treatment Refusal | 2015 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prodrugs; Psychotic Disorders; Schizophrenia | 2002 |
Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate.
Topics: Administration, Oral; Antipsychotic Agents; Dibenzothiazepines; Drug Administration Schedule; Haloperidol; Humans; Injections; Psychotic Disorders; Quetiapine Fumarate; Research Design; Sample Size; Schizophrenia; Treatment Outcome | 2006 |
[Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states].
Topics: Adult; Delusions; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychotic Disorders; Schizophrenia | 1984 |
The use of depot neuroleptic haloperidol decanoate.
Topics: Bipolar Disorder; Depressive Disorder; Haloperidol; Humans; Prognosis; Psychotic Disorders; Schizophrenia | 1984 |
How much haldol D does Larry really need?
Topics: Administration, Oral; Adult; Antipsychotic Agents; Drug Administration Schedule; Female; Haloperidol; Humans; Injections, Intramuscular; Psychotic Disorders | 1995 |
A loading-dose strategy for converting from oral to depot haloperidol.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Injections, Intramuscular; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Retrospective Studies; Schizophrenia; Schizophrenic Psychology | 1993 |
Haloperidol decanoate pharmacokinetics in red blood cells and plasma.
Topics: Adult; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Erythrocytes; Female; Haloperidol; Humans; Male; Metabolic Clearance Rate; Psychiatric Status Rating Scales; Psychotic Disorders | 1992 |
Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
Topics: Adult; Catatonia; Diagnosis, Differential; Haloperidol; Humans; Injections, Intramuscular; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders | 1990 |
[Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients].
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Drug Evaluation; Female; Haloperidol; Humans; Inpatients; Middle Aged; Psychotic Disorders | 1985 |
Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Kinetics; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders | 1986 |
Depot neuroleptics for acutely psychotic patients.
Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders | 1987 |